Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus

Mark K. Dodson, William Arthur Cliby, Hong Ji Xu, Karen A. DeLacey, Shi Xue Hu, Gary Keeney, Jian Li, Karl C. Podratz, Robert Brian Jenkins, William F. Benedict

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

The presence of retinoblastoma (RB) protein was evaluated by immunohistochemical staining and correlated with loss of heterozygosity (LOH) at the RB locus in 52 primary epithelial ovarian carcinomas. Forty-eight tumors were informative at the RB locus by molecular genetic analysis. Twenty-five tumors (52%) showed loss of heterozygosity at the RB locus. RB protein expression was found in 23 of these tumors. The remaining two tumors were negative for RB protein product by immunohistochemical staining. All 23 tumors showing no LOH at the RB locus had a normal RB protein pattern. All but three tumors revealed either no LOH with any marker or, if LOH was found for one chromosome 13 marker, all other informative markers also showed LOH. The three recombinant tumors included two which retained alleles at one or more loci distal and one which retained alleles proximal to the RB locus. LOH at the RB locus was significantly more common in invasive high-grade (grades 3 and 4) tumors as compared to invasive low-grade (grades 1 and 2) tumors (P < 0.001). Our data suggest that while molecular genetic studies reveal frequent LOH at the RB locus, particularly in high-grade tumors, normal RB protein expression is present in the majority (96%) of these tumors. This implies that another, unidentified, gene or genes located on chromosome 13 may be important in the progression of most epithelial ovarian carcinomas. Additionally, it is likely that the specific chromosome 13 alteration(s) associated with sporadic ovarian neoplasms will be extremely difficult to identify using allelic loss and deletion mapping studies.

Original languageEnglish (US)
Pages (from-to)610-613
Number of pages4
JournalCancer Research
Volume54
Issue number3
StatePublished - Feb 1 1994

Fingerprint

Retinoblastoma Protein
Retinoblastoma
Loss of Heterozygosity
Carcinoma
Neoplasms
Chromosomes, Human, Pair 13
Molecular Biology
Alleles
Staining and Labeling
Genetic Markers
Ovarian Neoplasms
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. / Dodson, Mark K.; Cliby, William Arthur; Xu, Hong Ji; DeLacey, Karen A.; Hu, Shi Xue; Keeney, Gary; Li, Jian; Podratz, Karl C.; Jenkins, Robert Brian; Benedict, William F.

In: Cancer Research, Vol. 54, No. 3, 01.02.1994, p. 610-613.

Research output: Contribution to journalArticle

Dodson, MK, Cliby, WA, Xu, HJ, DeLacey, KA, Hu, SX, Keeney, G, Li, J, Podratz, KC, Jenkins, RB & Benedict, WF 1994, 'Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus', Cancer Research, vol. 54, no. 3, pp. 610-613.
Dodson, Mark K. ; Cliby, William Arthur ; Xu, Hong Ji ; DeLacey, Karen A. ; Hu, Shi Xue ; Keeney, Gary ; Li, Jian ; Podratz, Karl C. ; Jenkins, Robert Brian ; Benedict, William F. / Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. In: Cancer Research. 1994 ; Vol. 54, No. 3. pp. 610-613.
@article{aeffe4540a884890898bfb11c5bc8d3d,
title = "Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus",
abstract = "The presence of retinoblastoma (RB) protein was evaluated by immunohistochemical staining and correlated with loss of heterozygosity (LOH) at the RB locus in 52 primary epithelial ovarian carcinomas. Forty-eight tumors were informative at the RB locus by molecular genetic analysis. Twenty-five tumors (52{\%}) showed loss of heterozygosity at the RB locus. RB protein expression was found in 23 of these tumors. The remaining two tumors were negative for RB protein product by immunohistochemical staining. All 23 tumors showing no LOH at the RB locus had a normal RB protein pattern. All but three tumors revealed either no LOH with any marker or, if LOH was found for one chromosome 13 marker, all other informative markers also showed LOH. The three recombinant tumors included two which retained alleles at one or more loci distal and one which retained alleles proximal to the RB locus. LOH at the RB locus was significantly more common in invasive high-grade (grades 3 and 4) tumors as compared to invasive low-grade (grades 1 and 2) tumors (P < 0.001). Our data suggest that while molecular genetic studies reveal frequent LOH at the RB locus, particularly in high-grade tumors, normal RB protein expression is present in the majority (96{\%}) of these tumors. This implies that another, unidentified, gene or genes located on chromosome 13 may be important in the progression of most epithelial ovarian carcinomas. Additionally, it is likely that the specific chromosome 13 alteration(s) associated with sporadic ovarian neoplasms will be extremely difficult to identify using allelic loss and deletion mapping studies.",
author = "Dodson, {Mark K.} and Cliby, {William Arthur} and Xu, {Hong Ji} and DeLacey, {Karen A.} and Hu, {Shi Xue} and Gary Keeney and Jian Li and Podratz, {Karl C.} and Jenkins, {Robert Brian} and Benedict, {William F.}",
year = "1994",
month = "2",
day = "1",
language = "English (US)",
volume = "54",
pages = "610--613",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus

AU - Dodson, Mark K.

AU - Cliby, William Arthur

AU - Xu, Hong Ji

AU - DeLacey, Karen A.

AU - Hu, Shi Xue

AU - Keeney, Gary

AU - Li, Jian

AU - Podratz, Karl C.

AU - Jenkins, Robert Brian

AU - Benedict, William F.

PY - 1994/2/1

Y1 - 1994/2/1

N2 - The presence of retinoblastoma (RB) protein was evaluated by immunohistochemical staining and correlated with loss of heterozygosity (LOH) at the RB locus in 52 primary epithelial ovarian carcinomas. Forty-eight tumors were informative at the RB locus by molecular genetic analysis. Twenty-five tumors (52%) showed loss of heterozygosity at the RB locus. RB protein expression was found in 23 of these tumors. The remaining two tumors were negative for RB protein product by immunohistochemical staining. All 23 tumors showing no LOH at the RB locus had a normal RB protein pattern. All but three tumors revealed either no LOH with any marker or, if LOH was found for one chromosome 13 marker, all other informative markers also showed LOH. The three recombinant tumors included two which retained alleles at one or more loci distal and one which retained alleles proximal to the RB locus. LOH at the RB locus was significantly more common in invasive high-grade (grades 3 and 4) tumors as compared to invasive low-grade (grades 1 and 2) tumors (P < 0.001). Our data suggest that while molecular genetic studies reveal frequent LOH at the RB locus, particularly in high-grade tumors, normal RB protein expression is present in the majority (96%) of these tumors. This implies that another, unidentified, gene or genes located on chromosome 13 may be important in the progression of most epithelial ovarian carcinomas. Additionally, it is likely that the specific chromosome 13 alteration(s) associated with sporadic ovarian neoplasms will be extremely difficult to identify using allelic loss and deletion mapping studies.

AB - The presence of retinoblastoma (RB) protein was evaluated by immunohistochemical staining and correlated with loss of heterozygosity (LOH) at the RB locus in 52 primary epithelial ovarian carcinomas. Forty-eight tumors were informative at the RB locus by molecular genetic analysis. Twenty-five tumors (52%) showed loss of heterozygosity at the RB locus. RB protein expression was found in 23 of these tumors. The remaining two tumors were negative for RB protein product by immunohistochemical staining. All 23 tumors showing no LOH at the RB locus had a normal RB protein pattern. All but three tumors revealed either no LOH with any marker or, if LOH was found for one chromosome 13 marker, all other informative markers also showed LOH. The three recombinant tumors included two which retained alleles at one or more loci distal and one which retained alleles proximal to the RB locus. LOH at the RB locus was significantly more common in invasive high-grade (grades 3 and 4) tumors as compared to invasive low-grade (grades 1 and 2) tumors (P < 0.001). Our data suggest that while molecular genetic studies reveal frequent LOH at the RB locus, particularly in high-grade tumors, normal RB protein expression is present in the majority (96%) of these tumors. This implies that another, unidentified, gene or genes located on chromosome 13 may be important in the progression of most epithelial ovarian carcinomas. Additionally, it is likely that the specific chromosome 13 alteration(s) associated with sporadic ovarian neoplasms will be extremely difficult to identify using allelic loss and deletion mapping studies.

UR - http://www.scopus.com/inward/record.url?scp=0028036251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028036251&partnerID=8YFLogxK

M3 - Article

C2 - 8306318

AN - SCOPUS:0028036251

VL - 54

SP - 610

EP - 613

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 3

ER -